Namyang Dairy Product's chairman and largest shareholder, Hong Won Sik, has been barred by the court from voting at the upcoming general meeting. This happened after the court granted Hahn & Co.'s injunction request to cancel the chief's voting rights.
Hahn & Co. is the buyer of Namyang Dairy Products, but the acquisition agreement has been delayed by Hong Won Sik, who appears to be regretting the sale. The court sided with the Seoul-based private equity investment firm after determining that the purchase agreement between the companies is valid despite the latter's claim that it is void for some reasons.
According to The Korea Herald, the ruling just shows that Namyang's chairman and his family were not able to present proof that Hahn & Co. violated a non-disclosure agreement, showed behavior that marred the thrust of the involved parties, or unlawfully intervened in the management.
The PEF company was accused of these offenses in an attempt to stop the sale and find another buyer. However, as stated, the other party could not show any valid evidence. In the ruling, it was mentioned that Hong and his family were the ones who did not stick to the terms of the deal, so their chance to demand the cancellation of the deal is very slim to no chance at all.
Now Hong will not be able to vote at the general shareholders meeting that was set for Oct. 29 as the Seoul Central District Court ordered Namyang Dairy to obey the injunction that revoked the chairman and his family's voting rights. The meeting was for naming four new board members, and it is expected to include an executive from Hanh & Co.
The Korea Economic Daily reported the court verdict that was handed down on Wednesday, Oct. 27, was issued as Hong Won Sik scrapped the ₩310.7 billion or $270 million agreement to sell a majority of his company to Hahn & Co following a series of delays for the transfer of controlling stake.
"It was confirmed their share purchase agreement (SPA) was closed as of 10 a.m. on July 30, and Chairman Hong's notification of the termination of the agreement is invalid," part of the ruling reads. "In addition, the SPA was aimed at allowing Hahn & Co to secure management rights of Namyang Dairy and Chairman Hong should be stopped from taking any action against it."


AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
U.S. Stock Index Futures Steady After S&P 500 Hits Record on Strong Economic Data
Global Markets Rise as Tech Stocks Lead, Yen Strengthens, and Commodities Hit Record Highs
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
UBS Warns of Short-Term Risks as Precious Metals Rally to Record Highs
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Taiwan Stock Market Ends Higher as Semiconductor and Energy Shares Lead Gains
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
US and Japan Fast-Track $550 Billion Strategic Investment Initiative
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
South Korea Central Bank Warns of Rising Financial Stability Risks Amid Won Volatility
Platinum Price Surges Past $2,000 as Demand and Supply Dynamics Tighten
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 



